These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12794830)

  • 1. A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C.
    Hwang KK; Yang CD; Yan W; Grossman JM; Hahn BH; Chen PP
    Arthritis Rheum; 2003 Jun; 48(6):1622-30. PubMed ID: 12794830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies.
    Ieko M; Ichikawa K; Triplett DA; Matsuura E; Atsumi T; Sawada K; Koike T
    Arthritis Rheum; 1999 Jan; 42(1):167-74. PubMed ID: 9920027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
    Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
    Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome.
    Lu CS; Horizon AA; Hwang KK; FitzGerald J; Lin WS; Hahn BH; Wallace DJ; Metzger AL; Weisman MH; Chen PP
    Arthritis Rheum; 2005 Dec; 52(12):4018-27. PubMed ID: 16320350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies.
    Ieko M; Sawada KI; Koike T; Notoya A; Mukai M; Kohno M; Wada N; Itoh T; Yoshioka N
    Semin Thromb Hemost; 1999; 25(5):503-7. PubMed ID: 10625210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice.
    Chen XX; Gu YY; Li SJ; Qian J; Hwang KK; Chen PP; Chen SL; Yang CD
    J Immunol; 2007 Apr; 178(8):5351-6. PubMed ID: 17404320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro.
    Tsakiris DA; Yasikoff ML; Wolf F; Marbet GA
    Ann Hematol; 1995 Oct; 71(4):195-8. PubMed ID: 7578527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
    Geng JP; Castellino FJ
    Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies.
    Zhu M; Olee T; Le DT; Roubey RA; Hahn BH; Woods VL; Chen PP
    Br J Haematol; 1999 Apr; 105(1):102-9. PubMed ID: 10233371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies.
    Galli M; Comfurius P; Barbui T; Zwaal RF; Bevers EM
    Thromb Haemost; 1992 Sep; 68(3):297-300. PubMed ID: 1440495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
    Geng JP; Cheng CH; Castellino FJ
    Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphospholipid antibodies and thrombosis: the putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody].
    Ieko M
    Rinsho Byori; 2000 Apr; 48(4):293-300. PubMed ID: 10810873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function assessment of the role of the helical stack domain in the properties of human recombinant protein C and activated protein C.
    Christiansen WT; Geng JP; Castellino FJ
    Biochemistry; 1995 Jun; 34(25):8082-90. PubMed ID: 7794921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-cardiolipin antibodies from New Zealand Black x New Zealand White F1 mice react to thrombomodulin.
    Haruta K; Kobayashi S; Hirose S; Horiai A; Ohyanagi M; Tanaka M; Kawano T; Shirai T; Takasaki Y; Hashimoto H
    J Immunol; 1998 Jan; 160(1):253-8. PubMed ID: 9551978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acids 225-235** of the protein C serine-protease domain are important for the interaction with the thrombin-thrombomodulin complex.
    Vincenot A; Gaussem P; Pittet JL; Debost S; Aiach M
    FEBS Lett; 1995 Jun; 367(2):153-7. PubMed ID: 7540990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
    Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
    Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
    Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
    Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.